Cytomegalovirus (CMV) glycoprotein B genotypes and response to antiviral therapy, in solid-organ-transplant recipients with CMV disease

Journal of Infectious Diseases

Volumn 188, Issue 4, 2003, Pages 581-584

  Humar, Atul ^a,d   Kumar, Deepali ^a   Gilbert, Christian ^b,c   Boivin, Guy ^b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; GANCICLOVIR; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS GLYCOPROTEIN B;

ARTICLE; CLINICAL ARTICLE; COLITIS; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG RESPONSE; GENOTYPE; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RECURRENT DISEASE; VIRUS HEPATITIS; VIRUS LOAD; VIRUS PNEUMONIA;

ANIMALS; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GANCICLOVIR; RECURRENCE; TRANSPLANTATION; VIRAL ENVELOPE PROTEINS; VIRAL LOAD;

EID: 0042442222     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/377002     Document Type: Article

References (15)

1. Hibberd PL, Snydman DR. Cytomegalovirus infection in organ transplant recipients. Infect Dis Clin North Am 1995; 9:863-77.
2. Humar A, Kumar D, Boivin G, Caliendo AM. Cytomegalovirus (CMV) viral load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease. J Infect Dis 2002; 186:829-33.
3. Rasmussen L. Molecular pathogenesis of human cytomegalovirus infection. Transpl Infect Dis 1999; 1:127-34
4. Hopkins JI, Fiander AN, Evans AS, Delchambre M, Gheysen K, Borysiewicz LK. Cytotoxic T cell immunity to human cytomegalovirus glycoprotein B. J Med Virol 1996; 49:124-31.
5. Navarro D, Paz P, Tugizov S, Topp K, La Vail J, Pereira L. Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. Virology 1993; 197:143-58.
6. Chou SW, Dennison KM. Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J Infect Dis 1991; 163:1229-34.
7. Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002; 34:1094-7
8. Sarcinella L, Mazzulli T, Willey B, Humar A. Cytomegalovirus glycoprotein B genotype does not correlate with outcomes in liver transplant patients. J Clin Virol. 2002; 24:99-105.
9. Gilbert C, Handfield J, Toma E, Lalonde R, Bergeron MG, Boivin G. Human cytomegalovirus glycoprotein B genotypes in blood of AIDS patients: lack of association with either the viral DNA load in leukocytes or presence of retinitis. J Med Virol 1999; 59:98-103.
10. Vogelburg C, Meyer-Konig U, Hufert FT, Kirste G, von Laer D. Human cytomegalovirus glycoprotein B genotypes in renal transplant recipients. J Med Virol 1996; 50:31-4.
11. Aquino VH, Figueiredo LTM. High prevalence of renal transplant recipients infected with more than one cytomegalovirus glycoprotein B genotype. J Med Virol 2000; 61:138-42.
12. Shepp DH, Match ME, Ashraf AB, Lipson SM, Millan C, Pergolizzi R. Cytomegalovirus glycoprotein B groups associated with retinitis in AIDS. J Infect Dis 1996; 174:184-7.
13. Drew WL, Chou S, Miner RC, et al. Cytomegalovirus glycoprotein B groups in human immunodeficiency virus-infected patients with incident retinitis. J Infect Dis 2002; 186:114-7.
14. Fries BC, Chou S, Boeckh M, Torok-Storb B. Frequency distribution of cytomegalovirus envelope glycoprotein genotypes in bone marrow transplant recipients. J Infect Dis 1994; 169:769-74.
15. Torok-Storb B, Boeckh M, Hoy C, Leisenring W, Myerson D, Gooley T. Association of specific cytomegalovirus genotypes with death from myelosuppression after marrow transplantation. Blood 1997; 90:2097-102.